Skip to main content
. 2018 Jun 8;159(8):2850–2862. doi: 10.1210/en.2018-00279

Table 2.

Femoral Trabecular Parameters as Evaluated by MicroCT

Treatment Group
P Value
3 mo
9 mo
Time Tx 3 mo vs 9 mo
Saline vs Fluoxetine
Saline (n = 7) Fluoxetine (n = 7) Saline (n = 8) Fluoxetine (n = 7) Saline Fluoxetine 3 mo 9 mo
BV/TV, % 3.5 ± 0.4 2.4 ± 0.4 1.4 ± 0.3 0.9 ± 0.2 < 0.0001 0.02 < 0.0001 0.0004 0.05 0.17
Tb.N, 1/mm 2.61 ± 0.08 2.54 ± 0.14 1.72 ± 0.07 1.74 ± 0.10 < 0.0001 0.77 < 0.0001 < 0.0001 0.62 0.92
Tb.S, μm 0.38 ± 0.01 0.40 ± 0.03 0.58 ± 0.03 0.59 ± 0.04 < 0.0001 0.87 < 0.0001 < 0.0001 0.80 0.98
Tb.Th, μm 0.044 ± 0.002 0.038 ± 0.003 0.046 ± 0.002 0.047 ± 0.004 0.05 0.39 0.53 0.04 0.17 0.85
Tiss.BMD, mg Hg/cm3 905 ± 17.06 904 ± 17.28 908 ± 8.09 903 ± 15.96 0.99 0.81 0.95 0.96 0.91 0.82

Abbreviations: Tb.N, trabecular number; Tb.S, trabecular spacing; Tb.Th, trabecular thickness; Tiss.BMD, tissue bone mineral density; Tx, treatment.